Involvement of ERK1/2 pathway in BPC-157-induced cell proliferation, migration, and tube formation To explore whether the ERK1/2, JNK, or p38 pathway was involved in BPC-157-induced cell proliferation, migration, and tube formation, PD98059 (ERK1/2 inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor) were used
It also appears in angiogenesis assay models and collagen-synthesis assays
BPC-157 is not FDA-approved and was placed in FDA 503A Category 2 in 2023 due to significant safety concerns, which restricts legal compounding
However, some reports suggest that the absorption of BPC-157 is enhanced when taken after a meal
Additionally, in SH-SY5Y cells, melatonin increased levels of Peptidyl-Prolyl cis-trans Isomerase NIMA-Interacting 1 (Pin1) [125], which has been shown to mitigate tau phosphorylation and aggregation [126]